Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.
Press releases published on May 5, 2025

Virtune announces change of Index Provider
Stockholm, 5 May 2025 - Virtune announces that as of May 12, 2025, the index provider for Virtune’s existing index ETPs will change to MarketVector IndexesTM (“MarketVector”). In addition, reference prices from MarketVector will be used for Virtune’s other …

Virtune meddelar byte av Indexleverantör
Stockholm, 5 maj 2025 - Virtune meddelar att från och med den 12 maj 2025 kommer indexleverantören för Virtunes existerande index-ETP:er att ändras till MarketVector IndexesTM (“MarketVector”). Därtill så kommer referenspriser från MarketVector att …

DOE Legacy Management Expertise Tapped for Rifle Disposal Cell Pore Water Extraction Project
RIFLE, COLORADO, May 05, 2025 (GLOBE NEWSWIRE) -- When the U.S. Department of Energy (DOE) Office of Legacy Management (LM) recently faced an operational challenge at the Rifle Disposal Site in Colorado, it took subject matter experts across a wide array …

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 5.5.2025 KLO 17.00 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 May 2025 at 17:00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …

Foremost Clean Energy Announces Warrant Incentive Program
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce the initiation of a warrant incentive program (the “Incentive Program”) intended to …

TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Industrial Future
CEO and Chairman Gerard Barron testified before the House Committee on Natural Resources on “Exploring the Potential of Deep-Sea Mining to Expand American Mineral Production” Mr. Barron highlighted the abundant, unattached polymetallic nodule resource as a …

G7 should act as stabilizer and reformer to reshape international order, urges T7 report
Waterloo, Canada, May 05, 2025 (GLOBE NEWSWIRE) -- A new report to the Group of 7 (G7) suggests the nations’ leaders should set directions to help address root causes of instability while also innovating in new areas at the global level. The Think7 …

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the pricing of an underwritten public offering …

STMicroelectronics Announces Status of Common Share Repurchase Program
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 28, 2025 to May 2, 2025 AMSTERDAM – May 5, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …

Revival Gold Files NI 43-101 Preliminary Economic Assessment for the Mercur Gold Project
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) has filed on SEDAR+ a technical report prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral …

AAFA Calls on Congress to Restore Lifesaving National Asthma Control Program
Washington, DC, May 05, 2025 (GLOBE NEWSWIRE) -- On May 6, 2025 – World Asthma Day – the Asthma and Allergy Foundation of America (AAFA) will visit the U.S. Capitol to call on Congress to protect the 28 million people in the U.S. with asthma and restore …

Ducommun to Participate in 2025 Truist Securities Industrials & Services Conference
COSTA MESA, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G. Oswald, the Company’s chairman, president and chief executive officer will participate in the upcoming 2025 …

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States), May 5, 2025 – Inventiva (Euronext Paris and Nasdaq: …

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros
Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables. Daix (France), New York City (New York …

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months from date of diagnosis [95% CI; 17 …

NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1900 (NBTXR3) DANS LE CANCER DU PANCREAS
Les résultats ont démontré un bon profil de tolérance, une faisabilité d’injection satisfaisante, ainsi que des signaux cliniques encourageants en matière d‘activité antitumorale chez des patients atteints d’un cancer du pancréas localement avancé ou à la …

GENFIT to Present Latest ACLF Research at EASL Congress 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 5 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …